Search Within

Matthew J Matasar

  1. "Center for Hematologic Malignancies"
  2. "Bone Marrow Transplant"
  3. "Paul Hamlin"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (11)
Groups
  1. Bone Marrow Transplant (31)
  2. Center for Hematologic Malignancies (31)
  3. Department of Medicine (31)
  4. Hematologic Malignancies, Division of (31)
  5. Lymphoma (31)
  6. Survivorship Research (31)

More Groups

People
  1. Paul Hamlin (31)
  2. Andrew Zelenetz (28)
  3. Ariela Noy (24)
  4. Craig Sauter (24)
  5. Maria Palomba (24)
  6. Steven Horwitz (24)

More People

Years
  1. 2022 (1)
  2. 2021 (4)
  3. 2020 (2)
  4. 2019 (3)
  5. 2018 (2)
  6. 2017 (6)

More Years

Publications
  1. Blood (16)
  2. Biology of Blood and Marrow Transplantation (4)
  3. Hematological Oncology (3)
  4. Blood Advances (2)
  5. Clinical Lymphoma, Myeloma and Leukemia (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Elsevier Inc. (6)
  3. Wiley Blackwell (3)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Science, Inc. (1)
  6. Ferrata Storti Foundation (1)

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Journal Article

    Dahi, P. B.; Tamari, R.; Devlin, S. M.; Maloy, M.; Bhatt, V.; Scordo, M.; Goldberg, J.; Zelenetz, A. D.; Hamlin, P. A.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission
    Journal Article

    Mehta, N.; Maragulia, J. C.; Moskowitz, A.; Hamlin, P. A.; Lunning, M. A.; Moskowitz, C. H.; Zelenetz, A.; Matasar, M. J.; Sauter, C.; Goldberg, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2013)

    Fulltext@MSK | Save
  • High dose therapy and autologous stem cell transplantation results in good outcomes and acceptable toxicities in elderly patients with non-Hodgkin's lymphoma
    Meeting Abstract

    Tamari, R.; Dahi, P.; Devlin, S.; Goldberg, J.; Hamlin, P.; Matasar, M.; Maragulia, J.; Perales, M. A.; Moskowitz, C. H.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Hamlin, P. A. Jr; Perales, M. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save